These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9123831)
1. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Kawanishi M Virology; 1997 Feb; 228(2):244-50. PubMed ID: 9123831 [TBL] [Abstract][Full Text] [Related]
2. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Floettmann JE; Ward K; Rickinson AB; Rowe M Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537 [TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of apoptosis by the latent infection membrane protein 1 of Epstein-Barr virus]. Kawanishi M Nihon Rinsho; 1997 Feb; 55(2):305-10. PubMed ID: 9046815 [TBL] [Abstract][Full Text] [Related]
5. [Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins]. Kawanishi M Nihon Rinsho; 1996 Jul; 54(7):1848-54. PubMed ID: 8741677 [TBL] [Abstract][Full Text] [Related]
6. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943 [TBL] [Abstract][Full Text] [Related]
7. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways. Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477 [TBL] [Abstract][Full Text] [Related]
8. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Okan I; Wang Y; Chen F; Hu LF; Imreh S; Klein G; Wiman KG Oncogene; 1995 Sep; 11(6):1027-31. PubMed ID: 7566960 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis. Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1]. Chen Y; Chen XY Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040 [TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. Kawanishi M Virology; 2000 May; 270(2):258-66. PubMed ID: 10792984 [TBL] [Abstract][Full Text] [Related]
13. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes. Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673 [TBL] [Abstract][Full Text] [Related]
14. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210 [TBL] [Abstract][Full Text] [Related]
15. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A; Pfaff P; Lange W; Finke J Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686 [TBL] [Abstract][Full Text] [Related]
16. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1]. Huang H; Huang PC Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of leukocyte infiltration in murine tumors expressing B-cell derived but not nasopharyngeal carcinoma derived EBV membrane protein LMP1. Trivedi P; Cuomo L; Christensson B; Hu LF; Morrone S; Frati L; Faggioni A; Winberg G; Klein G J Med Virol; 2000 Apr; 60(4):417-24. PubMed ID: 10686025 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions. Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]